Evidence map›Paper›PMID 39540964›Full record

ArticleEJNMMI physics2024

How much do

L Struelens, E Aalbersberg, L Beels, N Cherbuin, Y D'Asseler, F De Monte, A Lopez Medina, M Del Carmen Riveira Martin, W Schoonjans, C Terwinghe and 4 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in EJNMMI physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

L StruelensBelgian Nuclear Research Center (SCK CEN), Nuclear Medical Applications, Mol, Belgium. lara.struelens@sckcen.be.ORCID http://orcid.org/0000-0003-4696-9370
E AalbersbergDepartment of Nuclear Medicine, Netherlands Cancer Institute, Amsterdam, The Netherlands.
L BeelsNuclear Medicine Department, AZ Groeninge, Kortrijk, Belgium.
N CherbuinInstitute of Radiation Physics (IRA), Lausanne University Hospital, Lausanne, Switzerland.
Y D'AsselerDepartment of Diagnostic Sciences, University Hospital Ghent and Ghent University, Ghent, Belgium.
F De MonteMedical Physics Department, IRCCS, Veneto Institute of Oncology (IOV), Padua, Italy.
A Lopez MedinaMedical Physics Department (SERGAS), Hospital do Meixoeiro, Vigo, Spain.
M Del Carmen Riveira MartinMedical Physics Department (SERGAS), Hospital do Meixoeiro, Vigo, Spain.
W SchoonjansBelgian Nuclear Research Center (SCK CEN), Nuclear Medical Applications, Mol, Belgium.
C TerwingheDepartment of Nuclear Medicine, University Hospital Gasthuisberg, Leuven, Belgium.
S Van den BlockNuclear Medicine Department, Vrije Universiteit Brussel (VUB), Universitair Ziekenhuis Brussel (UZ Brussel), Brussels, Belgium.
F VanhavereBelgian Nuclear Research Center (SCK CEN), Nuclear Medical Applications, Mol, Belgium.
H ZaidiDivision of Nuclear Medicine and Molecular Imaging, Geneva University Hospital, Geneva, Switzerland.
V SchelfhoutDepartment of Diagnostic Sciences, University Hospital Ghent and Ghent University, Ghent, Belgium.

Funding

H2020 Euratom 945196
6 · The paper itself

Abstract

backgroundThe radiation exposure of nuclear medicine personnel, especially concerning extremity doses, has been a significant focus over the past two decades. This study addresses the evolving practice of NM, particularly with the rise of radionuclide therapy and theranostic procedures, which involve a variety of radionuclides such as

resultsMeasurements were conducted from November 2020 to August 2023 across nine hospitals. The highest whole-body, eye lens and extremity doses were observed for

conclusionsThis study's measurement campaigns across various European countries have provided new and extensive occupational dosimetry data for nuclear medicine staff handling

Indexed as

131Iodine177Lutetium68GalliumNuclear medicine staffOccupational exposure

Identifiers

PMID39540964
PMCPMC11564452

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.